Adamas scores $40M, Navy funds to tackle the flu
Adamas Pharmaceuticals, one of Mohr Davidow Ventures‘ key life science investments, has raised $40 million in a fourth round of funding to develop antiviral treatments for the flu virus. Based in Emeryville, Calif., the company also just signed a research agreement with the U.S. Navy to accelerate drug development in this area.
The funding is significant not only due to its size in a lean time for life science companies, but also because the flu has… Continue Reading
AOptix nabs $12.9M for eye-recognition
AOptix Technologies, developer of iris-recognition technology and the wireless communication systems it requires, has brought in $12.9 million in a fourth round of funding to build new products. The Campbell, Calif. company says it is in the middle of commercializing its first product, called the InSight 2 Meter Iris Recognition System. It has also benefited from recent defense contracts for its long-distance and high-bandwidth wireless systems.
Northgate Capital led the round, joined by Kleiner Perkins Caufield… Continue Reading
Arresto lands funds to treat cancer and fibrotic disease
Arresto Biosciences, maker of a drug that targets both cancer and fibrotic diseases, just landed an undisclosed third round of funding to push its lead compound closer to clinical trials. The Palo Alto, Calif. company is taking a new approach to the destruction of tumors. Instead of killing their cells directly, its drug would eliminate elements of the host environment that tumors need to metastasize and survive. This could prove helpful at extremely early or… Continue Reading
Consentry nabs $9.4M for tighter network control
Consentry Networks, a Milpitas, Calif. company that gives network administrators more direct control over computing infrastructure and applications, just raised $9.4 million from DAG Ventures, Invesco Private Capital, Northgate Capital, Translink Capital and Vedanta Capital.
The new money will go toward development of its network management product LANShield, a platform that gives users visibility into and control over all of the various operations and applications active on a system at any given time, the company claims…. Continue Reading
Cellective raises $5M bridge for cancer diagnostics
Cellective Dx announced that it brought in a $5 million bridge to a $25 million second round of funding. The Mountain View, Calif.-based company will use the money to continue development of cancer diagnostic tools that analyze tumor cells in blood. The method is supposed to help doctors determine the best course of treatment.
The funding is expected to last through the end of 2010. That’s enough to span two more commercialized tests of the products,… Continue Reading
EdeniQ quietly raises $33 million for cellulosic ethanol
updated
EdeniQ, an Encino, Calif.-based cellulosic ethanol startup, has quietly wrapped up a $33 million round of funding as part of its spinoff from parent company Altra Biofuels. PE Hub reports that Advanced Equities Investments and Draper Fisher Jurvetson were the lead investors; other backers include Element Partners, Angeleno Group, The Westly Group, Omninet, DAG Ventures and Northgate Capital.
EdeniQ claims its processes for converting non-food biomass sources into cellulosic ethanol can be implemented for “a fraction… Continue Reading
E-commerce company MarketLive raises $20M
MarketLive, a provider of e-commerce retail technology and services, has raised a new $20 million round of financing. Backers include new investors JAFCO Ventures and Northgate Capital, as well as Sequoia Capital, Sigma Partners, Globespan Capital and others.
MarketLive was founded in 1995, and it’s still growing. The Foster City, Calif. company says it added 33 new brands to its portfolio and launched 56 new sites last year. This is MarketLive’s fifth round of funding, according… Continue Reading